Latest | F'cast | |
---|---|---|
Div Yield | 1.5% | 0.0% |
Div Cover | 1.3 | 1.4 |
Op Mrgn | 5.4% | 19.2% |
ROCE | 6.5% |
Latest | F'cast | |
---|---|---|
P/E | 51.5 | 37.2 |
PEG | n/a | 2.3 |
Pr/Revenue | 6.6 | 5.0 |
Pr/Book | 7.1 |
Latest | F'cast | |
---|---|---|
Revenue | 0.4% | 9.6% |
PBT | -60.2% | 337.0% |
EPS | -26.1% | 13.7% |
DPS | n/a | 2.7% |
Year Ending | Revenue (£m) | Pre-tax (£m) | EPS | P/E | PEG | EPS Grth. | Div | Yield |
---|---|---|---|---|---|---|---|---|
30-Jun-18 | 22.22 | 4.01 | 9.16p | 34.9 | 3.5 | +10% | 4.58p | 1.4% |
30-Jun-19 | 26.17 | 4.75 | 11.08p | 25.9 | 1.2 | +21% | 5.54p | 1.9% |
30-Jun-20 | 31.68 | 6.64 | 12.35p | 34.4 | 2.9 | +12% | 6.18p | 1.5% |
30-Jun-21 | 31.00 | 3.76 | 11.36p | 56.2 | n/a | -8% | 6.55p | 1.0% |
30-Jun-22 | 31.12 | 1.50 | 8.40p | 42.0 | n/a | -26% | 6.55p | 1.9% |
a. Based on UK GAAP presentation of accounts - includes discontinued activities
Year Ending | Revenue (£m) | Pre-tax (£m) | EPS | P/E | PEG | EPS Grth. | Div | Yield |
---|---|---|---|---|---|---|---|---|
30-Jun-23 | 34.10 | 6.53 | 9.55p | 45.3 | 3.3 | +14% | 6.73p | 0.0% |
30-Jun-24 | 38.30 | 7.60 | 11.24p | 38.5 | 2.2 | +18% | 6.70p | 0.0% |
30-Jun-25 | 43.75 | 9.50 | 13.46p | 32.1 | 1.6 | +20% | 6.96p | 0.0% |
Copyright © 2023 FactSet Research Systems Inc. All rights reserved.
Exercise of Share Options and Total Voting Rights | 06-Jun-2023 | 17:00 | RNS |
Analyst and Investor presentation | 05-Jun-2023 | 10:00 | RNS |
FDA De Novo approval | 05-Jun-2023 | 07:00 | RNS |
Broker tips: Fevertree,Tristel | 25-May-2023 | ShareCast |
Numis starts coverage of Tristel at 'add' | 25-May-2023 | ShareCast |
Tristel books strong first-half as it enters Nor... | 20-Feb-2023 | ShareCast |
Cash planted into TEG | 11-Nov-2007 | Scotland on Sunday |
Space at a premium | 05-Nov-2006 | Scotland on Sunday |
No deals were found in the last 28 days.
Currency | UK Pounds |
Share Price | 432.50p |
Change Today | 2.50p |
% Change | 0.58 % |
52 Week High | 438.45 |
52 Week Low | 295.00 |
Volume | 104,347 |
Shares Issued | 47.26m |
Market Cap | £204.41m |
RiskGrade | 180 |
Value |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
---|
Price Trend |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
---|
Income |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
---|
Growth |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
---|
Strong Buy | 1 |
Buy | 1 |
Neutral | 0 |
Sell | 0 |
Strong Sell | 0 |
Total | 2 |
Latest | Previous | |
---|---|---|
Interim | Final | |
Ex-Div | 16-Mar-23 | 17-Nov-22 |
Paid | 11-Apr-23 | 16-Dec-22 |
Amount | 2.62p | 3.93p |
Time | Volume / Share Price |
17:07 | 3,000 @ 432.50p |
15:31 | 13,000 @ 434.95p |
16:23 | 2,000 @ 431.00p |
15:17 | 11,000 @ 435.97p |
16:08 | 80 @ 434.90p |
CEO | Paul Christopher Swinney |
Finance Director | Elizabeth Dixon |
You are here: research